Osimertinib: Northern Ireland
(asked on 28th June 2021) - View Source
Question to the Department of Health and Social Care:
To ask Her Majesty's Government whether Tagrisso is available to patients in Northern Ireland on the same basis as it is to patients in Great Britain; and if not, what are the differences in its availability.
This question was answered on 8th July 2021
The Medicines and Healthcare products Regulatory Agency recently authorised a new indication for Tagrisso in Great Britain to help treat early stage non-small cell lung cancer patients. This indication for Tagrisso has been authorised by the European Medicines Agency and can be prescribed to patients in Northern Ireland on the same basis as in Great Britain.